TrialJournal of affective disorders2013

Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study.

Jose A Franco-Chaves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.